| 2D Structure | |
| CID | 5969616 |
| IUPAC Name | (E)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide |
| InChI | InChI=1S/C20H20N2O4/c1-26-19-10-13(2-6-18(19)24)3-7-20(25)21-9-8-14-12-22-17-5-4-15(23)11-16(14)17/h2-7,10-12,22-24H,8-9H2,1H3,(H,21,25)/b7-3+ |
| InChI Key | WGHKJYWENWLOMY-XVNBXDOJSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C20H20N2O4 |
| Molecular Weight | 352.4 |
| synonyms | ['Moschamine', 'N-Feruloylserotonin', 'N-Feruloyl Serotonin', '68573-23-9', 'feruloylserotonin', 'Feruloylserotonin 98', 'UNII-2PP8322487', 'ferulic acid serotonin amide', 'CHEBI:85158', 'DTXSID70172925', '2-Propenamide, N-(2-(5-hydroxy-1H-indol-3-yl)ethyl)-3-(4-hydroxy-3-methoxyphenyl)-, (2E)-', '2-Propenamide, N-(2-(5-hydroxy-1H-indol-3-yl)ethyl)-3-(4-hydroxy-3-methoxyphenyl)-, (E)-', 'RefChem:163374', 'DTXCID5095416', 'N-FERULOYL SEROTONIN [INCI]', '849-485-8', '193224-22-5', '(E)-N-(2-(5-Hydroxy-1H-indol-3-yl)ethyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide', '(2E)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide', 'TRYPTAMINE, N-FERULOYL', '(E)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide', 'CHEMBL564482', '2PP8322487', 'N-(2-(5-Hydroxy-1H-indol-3-yl)ethyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide', 'N-[2-(5-Hydroxy-1H-indol-3-yl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)-2-propenamide; N-Feruloylserotonin; NSC 369502;', 'MFCD28125425', 'SEROTONIN (I), N-(FERULOYL)-', 'Nb-(E)-Feruloylserotonin', 'N-(Feruloyl)-Serotonin (I)', 'orb1685029', 'orb1739424', 'SCHEMBL12063415', 'SCHEMBL30037765', 'GLXC-10976', 'BDBM50296246', 'EBC-518564', 'HY-118824A', 'NSC-369502', 'N-[2-(5-Hydroxy-1H-indol-3-yl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)-2-propenamide', 'DA-75683', 'MS-25464', 'CS-0068597', 'CS-0131111', 'G14381', 'Q25099720', '(e)-N-(3-methoxy-4-hydroxycinnamoyl)-5-hydroxytryptamine', '(E)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enamide'] |
From Pubchem